14-Bromo, 13-Deoxo, 13,13-Dimethoxy Daunorubicin Hydrobromide (>85%)

CAS: 148218-14-8

Ref. TR-A630405

Informação sobre produto

• Nome: 14-Bromo, 13-Deoxo, 13,13-Dimethoxy Daunorubicin Hydrobromide (>85%)
• Sinónimos: 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrobromide, (8S-cis)- (9CI), 13,13-Dimethoxy-14-bromodaunorubicin hydrobromide, (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrobromide
• CAS: 148218-14-8

Descrição

Applications (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione, is the metabolite of Doxorubicin (D558000), which is a neoplasm inhibitor,and an antineoplastic.
References Smith, T.H., et al.: J. Med. Chem., 22, 40 (1979); Di Marco, A., et al.: Cancer Chemother. Rep., (part 1), 53, 33 (1969), Mihich, E. and Ehrke, M.J.: Transplant. Proc., 16, 499 (1984),

• Marca: TRC

Propriedades químicas

• Peso molecular: 733.40
• Fórmula: C₂₉H₃₅Br₂NO₁₁
• Pureza: >85%
• Cor/forma: Neat
• InChI: InChI=1S/C29H34BrNO11.BrH/c1-12-23(32)15(31)8-18(41-12)42-17-10-28(37,29(11-30,39-3)40-4)9-14-20(17)27(36)22-21(25(14)34)24(33)13-6-5-7-16(38-2)19(13)26(22)35;/h5-7,12,15,17-18,23,32,34,36-37H,8-11,31H2,1-4H3;1H/t12-,15-,17-,18-,23+,28-;/m0./s1
• Chave InChI: InChIKey=ZJMNKJBMLXACAJ-HBCRAIDQSA-N
• SMILES: Br.COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(CBr)(OC)OC)C[C@@H]3O[C@H]1C[C@@H](N)[C@@H](O)[C@H](C)O1